Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.74 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.74 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.63 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.62 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zingerone SCHEMBL14763994 | 1.00 | ALOX5 (0.74) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| Zingerone SCHEMBL119051 | 1.00 | ALOX5 (0.74) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| Zingerone SCHEMBL29828498 | 1.00 | ALOX5 (0.74) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| Zingerone SCHEMBL28865670 | 0.93 | ALOX5 (0.65) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| Zingerone SCHEMBL27825673 | 0.91 | ALOX5 (0.63) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| SCHEMBL27488164 | 0.90 | MTNR1A (0.68) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| Zingerone SCHEMBL11906310 | 0.89 | ALOX5 (0.74) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| SCHEMBL28355932 | 0.88 | ALOX5 (0.88) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| SCHEMBL2467651 | 0.88 | ALOX5 (0.86) | ALOX5OR51E2TAAR1TSHRMAPK1 | |
| SCHEMBL29986264 | 0.88 | ALOX5 (0.86) | ALOX5OR51E2TAAR1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031287-A | A composition containing zingibenone A with repairing and anti-wrinkle effects and its preparation method | 大连双迪科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-3463588-B1 | USE OF GINGER ROOT CO2 EXTRACT | SYMRISE AG (DE) | 2025-09-17 | — | — | EP | claimed |
| CN-119968452-A | Perfume mixture (VI) | 西姆莱斯股份公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119790128-A | Perfume mixture (III) | 西姆莱斯股份公司 | 2025-04-08 | — | — | CN | claimed |
| US-20250108023-A1 | Products for Masking Bitterness | The Third People's Hospital of Henan Province (CN) | 2025-04-03 | — | — | US | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119317696-A | Perfume mixture (V) | 西姆莱斯股份公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119317695-A | Perfume mixture (V) | 西姆莱斯股份公司 | 2025-01-14 | — | — | CN | claimed |
| CN-118829416-A | Composition (III) | 西姆莱斯股份公司 | 2024-10-22 | — | — | CN | claimed |
| EP-4444095-A1 | ARTHROPOD CONTROL COMPOSITIONS | Firmenich SA (CH) | 2024-10-16 | — | — | EP | claimed |
| WO-2023112966-A1 | SPRAY DEVICE AND AIR TREATMENT DEVICE | ダイキン工業株式会社 | 2023-06-22 | — | — | WO | claimed |
| WO-2023064318-A1 | BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE | Natural Extraction Systems, LLC (US) | 2023-04-20 | — | — | WO | claimed |
| WO-2023046730-A1 | COSMETIC COMPOSITIONS CONTAINING CANNABIDIOL AND ZINGIBER EXTRACT | BIONORICA SE (DE) | 2023-03-30 | — | — | WO | claimed |
| US-11602496-B2 | Use of gingerone or derivatives thereof for reducing or delaying the signs of skin ageing | L'OREAL (FR) | 2023-03-14 | — | — | US | claimed |
| WO-2023031860-A1 | COMPOSITIONS, KITS, AND METHODS TO PROVIDE SYNERGISTIC AND/OR ADDITIVE EFFECTS FROM COMPRISED INGREDIENTS FOR THE PREVENTION, TREATMENT AND MANAGEMENT OF NAUSEA AND VOMITING. | PATEL, Natvarlal Hargovinddas (IN) | 2023-03-09 | — | — | WO | claimed |
| WO-2023031861-A1 | COMPOSITIONS, KITS, AND METHODS FOR TREATMENT OF NAUSEA AND VOMITING | PATEL, Natvarlal Hargovinddas (IN) | 2023-03-09 | — | — | WO | claimed |
| WO-2023031779-A1 | COMPOSITIONS, KITS, AND METHODS TO PROVIDE SYNERGISTIC AND/OR ADDITIVE EFFECTS FROM COMPRISED INGREDIENTS FOR THE PREVENTION, TREATMENT AND MANAGEMENT OF NAUSEA AND VOMITING | PATEL, Natvarlal Hargovinddas (IN) | 2023-03-09 | — | — | WO | claimed |
| EP-4106822-A1 | BAD-ODOR CONTROL USING ENCAPSULATION TECHNOLOGIES CONTAINING NEUTRALIZING AGENT | Henkel AG & Co. KGaA (DE) | 2022-12-28 | — | — | EP | claimed |
| EP-4103576-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | Glycoscience, S.L. (ES) | 2022-12-21 | — | — | EP | claimed |
| EP-4011352-A1 | NEW COSMETICS SOLVENTS BASED ON THREE DIFFERENT COMPONENTS | Beiersdorf AG (DE) | 2022-06-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11602496-B2 | Use of gingerone or derivatives thereof for reducing or delaying the signs of skin ageing | CYP11B1, AKR1C3, GLA | ALOX5 32/4885OR51E2 1514/4885TAAR1 2663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.